Metabolomics is an emerging field of omics science that measures thousands of small molecule metabolites in cells, tissues, and organisms. The Metabolomics Innovation Centre (TMIC) is Canada’s national platform for large-scale metabolomics research and technology development and has created novel metabolomic technologies for a wide range of applications, including human and animal health, agriculture, and nutrition. However, it currently lacks the tools that have allowed other omics sciences such as proteomics, genomics, or transcriptomics to become such commercial successes. To address this gap, this project seeks to facilitate commercialization of metabolomic discoveries and innovative tools (kits, databases, software, devices) arising from TMIC’s research. The MTDC will provide the infrastructure, human resources, scientific, and business expertise required to bridge the research translation gap and transfer these technologies from proof-of-principle concepts to smoothly functioning prototypes. These prototypes would be made available to companies and researchers for commercialization.